Table of Contents Author Guidelines Submit a Manuscript
AIDS Research and Treatment
Volume 2015 (2015), Article ID 103874, 8 pages
http://dx.doi.org/10.1155/2015/103874
Research Article

Resistance to Cotrimoxazole and Other Antimicrobials among Isolates from HIV/AIDS and Non-HIV/AIDS Patients at Bugando Medical Centre, Mwanza, Tanzania

1Department of Clinical Pharmacology, Weill Bugando School of Medicine, P.O. Box 1464, Mwanza, Tanzania
2Microbiology and Immunology Department, Weill Bugando School of Medicine, P.O. Box 1464, Mwanza, Tanzania
3Department of Community Medicine, School of Public Health, Catholic University of Health and Allied Sciences, P.O. Box 1464, Mwanza, Tanzania
4Department of Pharmacology, Mbarara University of Science and Technology, P.O. Box 1410, Mbarara, Uganda
5National Institute for Medical Research, P.O. Box 1462, Mwanza, Tanzania

Received 11 September 2014; Revised 20 January 2015; Accepted 31 January 2015

Academic Editor: Otoniel Martinez-Maza

Copyright © 2015 Karol J. Marwa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. N. Okeke, R. Laxminarayan, Z. A. Bhutta et al., “Antimicrobial resistance in developing countries. Part I: recent trends and current status,” The Lancet Infectious Diseases, vol. 5, no. 8, pp. 481–493, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. M. F. Mushi, S. E. Mshana, C. Imirzalioglu, and F. Bwanga, “Carbapenemase genes among multidrug resistant gram negative clinical isolates from a tertiary hospital in Mwanza, Tanzania,” BioMed Research International, vol. 2014, Article ID 303104, 6 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. R. D. Smith and J. Coast, “Antimicrobial resistance: a global response,” Bulletin of the World Health Organization, vol. 80, no. 2, pp. 126–133, 2002. View at Google Scholar · View at Scopus
  4. Resistance USITFoA, 2009-2010 Progress Towards Implementation of: A Public Health Action Plan to Combat Antimicrobial Resistance, Interagency Task Force on Antimicrobial Resistance, 2011.
  5. K. A. Johansson, D. Jerene, and O. F. Norheim, “National HIV treatment guidelines in Tanzania and Ethiopia: are they legitimate rationing tools?” Journal of Medical Ethics, vol. 34, no. 6, pp. 478–483, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Vila, M. Vargas, C. Casals et al., “Antimicrobial resistance of diarrheagenic Escherichia coli isolated from children under the age of 5 years from Ifakara, Tanzania,” Antimicrobial Agents and Chemotherapy, vol. 43, no. 12, pp. 3022–3024, 1999. View at Google Scholar · View at Scopus
  7. F. C. Tenover, “Mechanisms of antimicrobial resistance in bacteria,” The American Journal of Medicine, vol. 119, supplement 1, no. 6, pp. S3–S70, 2006. View at Google Scholar
  8. H. Maortua, A. Canut, B. Ibáñez, D. Martínez, M. J. De Domingo, and A. Labora, “Relationship between in-hospital bacterial resistance and antimicrobial use over a 13-year period,” Enfermedades Infecciosas y Microbiologia Clinica, vol. 27, no. 8, pp. 441–448, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. A.-M. Rogues, C. Dumartin, B. Amadéo et al., “Relationship between rates of antimicrobial consumption and the incidence of antimicrobial resistance in Staphylococcus aureus and Pseudomonas aeruginosa isolates from 47 French hospitals,” Infection Control and Hospital Epidemiology, vol. 28, no. 12, pp. 1389–1395, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Iosifidis, C. Antachopoulos, M. Tsivitanidou et al., “Differential correlation between rates of antimicrobial drug consumption and prevalence of antimicrobial resistance in a tertiary care hospital in Greece,” Infection Control and Hospital Epidemiology, vol. 29, no. 7, pp. 615–622, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. S. A. Madhi, K. Petersen, A. Madhi, M. Khoosal, and K. P. Klugman, “Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children,” Clinical Infectious Diseases, vol. 31, no. 1, pp. 170–176, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Cheesborough, “Microbiology,” in District Laboratory Practice in Tropical Countries Vol. II, pp. 158–195, Cambridge University Press, 2nd edition, 2006. View at Google Scholar
  13. M. A. Wikler, Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement, Clinical and Laboratory Standards Institute, 2010.
  14. M. J. Perilla, G. Ajello, C. Bopp et al., Manual for the Laboratory Identification and Antimicrobial Susceptibility Testing of Bacterial Pathogens of Public Health Importance in the Developing World: Haemophilus influenzae, Neisseria meningitidis, Streptococcus pneumoniae, Neisseria gonorrhoeae, Salmonella serotype Typhi, Shigella, and Vibrio cholerae, Centers for Disease Control and Prevention, National Center for Infectious Diseases, 2003.
  15. S. E. Mshana, E. Kamugisha, M. Mirambo, T. Chakraborty, and E. F. Lyamuya, “Prevalence of multi-resistant gram-negative organisms in a tertiary hospital in Mwanza, Tanzania,” BMC Research Notes, vol. 2, article 49, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. Jamii TWyAnUw, Programme NAC: National Guidelines for the Management of HIV and AIDS, National Aids Control Programme, 2008.
  17. R. Zachariah, M. P. Spielmann, A. D. Harries, P. Gomani, and E. Bakali, “Cotrimoxazole prophylaxis in HIV-infected individuals after completing anti-tuberculosis treatment in Thyolo, Malawi,” International Journal of Tuberculosis and Lung Disease, vol. 6, no. 12, pp. 1046–1050, 2002. View at Google Scholar · View at Scopus
  18. WHO, Provisional WHO/UNAIDS Secretariat Recommendations on the Use of Cotrimoxazole Prophylaxis in Adults and Children Living with HIV/AIDS in Africa, WHO, Geneva, Switzerland, 2000.
  19. E. Nelson, J. Kayega, J. Seni et al., “Evaluation of existence and transmission of extended spectrum beta lactamase producing bacteria from post-delivery women to neonates at Bugando Medical Center, Mwanza-Tanzania,” BMC Research Notes, vol. 7, no. 1, article 279, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Kayange, E. Kamugisha, D. L. Mwizamholya, S. Jeremiah, and S. E. Mshana, “Predictors of positive blood culture and deaths among neonates with suspected neonatal sepsis in a tertiary hospital, Mwanza-Tanzania,” BMC Pediatrics, vol. 10, no. 1, article 39, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Moremi, M. F. Mushi, M. Fidelis, P. Chalya, M. Mirambo, and S. E. Mshana, “Predominance of multi-resistant gram-negative bacteria colonizing chronic lower limb ulcers (CLLUs) at Bugando Medical Center,” BMC Research Notes, vol. 7, no. 1, article 211, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. S. C. Morpeth, N. M. Thielman, H. O. Ramadhani et al., “Effect of trimethoprim-sulfamethoxazole prophylaxis on antimicrobial resistance of fecal Escherichia coli in HIV-infected patients in Tanzania,” Journal of Acquired Immune Deficiency Syndromes, vol. 47, no. 5, pp. 585–591, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. A. S. Karstaedt, M. Khoosal, and H. H. Crewe-Brown, “Pneumococcal bacteremia during a decade in children in Soweto, South Africa,” Pediatric Infectious Disease Journal, vol. 19, no. 5, pp. 454–457, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Leibovitz, C. Dragomir, S. Sfartz et al., “Nasopharyngeal carriage of multidrug-resistant Streptococcus pneumoniae in institutionalized HIV-infected and HIV-negative children in northeastern Romania,” International Journal of Infectious Diseases, vol. 3, no. 4, pp. 211–215, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Ndugulile, R. Jureen, S. Harthug, W. Urassa, and N. Langeland, “Extended spectrum β-lactamases among Gram-negative bacteria of nosocomial origin from an Intensive Care Unit of a tertiary health facility in Tanzania,” BMC Infectious Diseases, vol. 5, article 86, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Skippen, M. Shemko, J. Turton, M. E. Kaufmann, C. Palmer, and N. Shetty, “Epidemiology of infections caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp.: a nested case-control study from a tertiary hospital in London,” Journal of Hospital Infection, vol. 64, no. 2, pp. 115–123, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Shakil, M. Akram, S. M. Ali, and A. U. Khan, “Acquisition of extended-spectrum β-lactamase producing Escherichia coli strains in male and female infants admitted to a neonatal intensive care unit: molecular epidemiology and analysis of risk factors,” Journal of Medical Microbiology, vol. 59, part 8, pp. 948–954, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Mermin, J. Lule, J. P. Ekwaru et al., “Cotrimoxazole prophylaxis by HIV-infected persons in Uganda reduces morbidity and mortality among HIV-uninfected family members,” AIDS, vol. 19, no. 10, pp. 1035–1042, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. M. F. Cotton, E. Wasserman, J. Smit, A. Whitelaw, and H. J. Zar, “High incidence of antimicrobial resistant organisms including extended spectrum beta-lactamase producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus in nasopharyngeal and blood isolates of HIV-infected children from Cape Town, South Africa,” BMC Infectious Diseases, vol. 8, article 40, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. X. Anglaret, G. Chêne, A. Attia et al., “Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Cote d'Ivoire: a randomised trial,” The Lancet, vol. 353, no. 9163, pp. 1463–1468, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. S. C. Morpeth, N. M. Thielman, H. O. Ramadhani et al., “Effect of trimethoprim-sulfamethoxazole prophylaxis on antimicrobial resistance of fecal Escherichia coli in HIV-infected patients in Tanzania,” Journal of Acquired Immune Deficiency Syndromes, vol. 47, no. 5, pp. 585–591, 2008. View at Publisher · View at Google Scholar · View at Scopus